SHILPAMEDNSEShilpa Medicare Limited· PharmaceuticalsMediumNeutral
Announced Wed, 24 Sept · 15:04 IST

Shilpa Medicare Limited has informed the Exchange about Assignment of ESG Rating by CRISIL ESG Ratings and Analytics

Credit & Debt View source PDF

SHILPAMED · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Shilpa Medicare has been assigned an ESG score of 'Crisil ESG 51' by CRISIL ESG Ratings & Analytics Limited, based on publicly available data for FY 2024-25. Importantly, the company did not engage CRISIL for this rating — it was independently prepared by CRISIL using public domain information. The disclosure is being made to the exchanges under SEBI Listing Regulations. A score of 51 on CRISIL's ESG scale (which goes up to 100) suggests a moderate performance on environmental, social, and governance parameters.

Likely market impact

This is an informational disclosure of a moderate ESG score assigned independently by CRISIL; it is not a credit rating and is unlikely to have a direct impact on the stock price, though institutional ESG-focused investors may factor it into their assessments.